AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Total assets

Chiome Bioscience Inc.【JP:4583】

Market cap
¥7.4B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Dec 31, 20251,728-30.03%
Dec 31, 20242,469+40.96%
Dec 31, 20231,751-20.94%
Dec 31, 20222,215-5.30%
Dec 31, 20212,339-33.05%
Dec 31, 20203,495+24.45%
Dec 31, 20192,808-0.82%
Dec 31, 20182,831-35.94%
Dec 31, 20174,419-7.72%
Dec 31, 20164,789-2.64%
Dec 31, 20154,919-19.52%
Dec 31, 20146,111

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)